Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry G Grabowski

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Health Affairs (Project Hope)|November 10, 2011
Evolving brand-name and generic drug competition may warrant a revision of the Hatch-Waxman ActHenry G Grabowski, Margaret Kyle, Richard Mortimer, et al.
Health Affairs (Project Hope)|March 9, 2006
Spending on postapproval drug safetyDavid B Ridley, Judith M Kramer, Hugh H Tilson, et al.
Transfusion|September 8, 2016
Risk-based decision making and ethical considerations in donor compensation for plasma-derived medicinal productsMark W Skinner, P Ann Hedlund Hoppe, Henry G Grabowski, et al.
JAMA|February 8, 2007
Economic return of clinical trials performed under the pediatric exclusivity programJennifer S Li, Eric L Eisenstein, Henry G Grabowski, et al.
American Heart Journal|October 18, 2008
The economic returns of pediatric clinical trials of antihypertensive drugsCarissa M Baker-Smith, Daniel K Benjamin, Henry G Grabowski, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Health Affairs (Project Hope)|November 10, 2011
Evolving brand-name and generic drug competition may warrant a revision of the Hatch-Waxman ActHenry G Grabowski, Margaret Kyle, Richard Mortimer, et al.
Health Affairs (Project Hope)|March 9, 2006
Spending on postapproval drug safetyDavid B Ridley, Judith M Kramer, Hugh H Tilson, et al.
Transfusion|September 8, 2016
Risk-based decision making and ethical considerations in donor compensation for plasma-derived medicinal productsMark W Skinner, P Ann Hedlund Hoppe, Henry G Grabowski, et al.
JAMA|February 8, 2007
Economic return of clinical trials performed under the pediatric exclusivity programJennifer S Li, Eric L Eisenstein, Henry G Grabowski, et al.
American Heart Journal|October 18, 2008
The economic returns of pediatric clinical trials of antihypertensive drugsCarissa M Baker-Smith, Daniel K Benjamin, Henry G Grabowski, et al.
Pageof 2